Genetic Study Reveals Why Loving Onions May Boost Your Health
Genetic Study Reveals Why Loving Onions May Boost Your Health
Genetic Study Reveals Why Loving Onions May Boost Your Health
An international team of scientists has uncovered a genetic link between a love for onions and better health. Their findings suggest that a specific genetic variant influences both onion preference and a reduced risk of certain diseases. The study was published in the journal BMC Medicine. The researchers analysed data from nearly half a million British adults in the UK Biobank. They examined over 1,200 genetic variants tied to taste and smell receptors. Among these, 268 variants showed strong associations with preferences for 96 different foods, including onions.
The olfactory receptor gene OR2T6 proved particularly significant. It was closely connected to how much people enjoyed and consumed onions. Using this gene as a proxy, the team applied Mendelian randomisation to establish causal relationships. They found that individuals with the onion-loving variant had lower blood pressure and a reduced risk of type 2 diabetes.
Onions contain bioactive compounds like quercetin, known for their anti-inflammatory and blood vessel-widening effects. The study provides strong evidence that these properties may help explain the observed health benefits. The discovery highlights how genetic factors shape dietary habits and health outcomes. It offers clear epidemiological support for the role of onions in lowering blood pressure and diabetes risk. The findings could inform future dietary recommendations for disease prevention.
German nursing care reform faces backlash over financial risks ahead of cabinet review
A €1.8 billion annual burden on pensions. Half of care home residents at risk of welfare. Why Germany's reform is under fire—and what happens next.
Region transforms healthcare with new hospitals and modernized rural clinics
From high-tech hospitals to rural clinic revamps, this region is rewriting its healthcare story. Thousands of patients will soon benefit from expanded access and cutting-edge facilities.
FDA panel with industry ties to review peptide injection safety in July
A controversial FDA panel, stacked with doctors profiting from peptides, will decide their fate. Will science or business interests shape the outcome?
Nursing homes in crisis as low wages spark staffing shortages and delays
Thousands wait for care as underpaid staff push nursing homes to the brink. Will strikes force a pay rise—or collapse the system further?